Pages that link to "Q35088515"
Jump to navigation
Jump to search
The following pages link to Induced pluripotent stem cells: opportunities and challenges (Q35088515):
Displaying 50 items.
- Thrombospondin-1 signaling through CD47 inhibits self-renewal by regulating c-Myc and other stem cell transcription factors (Q24633525) (← links)
- Rapid single-step induction of functional neurons from human pluripotent stem cells (Q26269862) (← links)
- Functional genomics of human brain development and implications for autism spectrum disorders (Q26778520) (← links)
- Pluripotent stem cells in research and treatment of hemoglobinopathies (Q26825713) (← links)
- Hypomyelinating leukodystrophies: translational research progress and prospects (Q27012678) (← links)
- Epigenetic mechanisms in mood disorders: targeting neuroplasticity (Q27021810) (← links)
- Functional cardiac tissue engineering (Q27024431) (← links)
- Benchtop technologies for circulating tumor cells separation based on biophysical properties (Q27028049) (← links)
- From pluripotency to forebrain patterning: an in vitro journey astride embryonic stem cells (Q27030826) (← links)
- Rapid and efficient conversion of integration-free human induced pluripotent stem cells to GMP-grade culture conditions (Q27342678) (← links)
- Genetic background affects induced pluripotent stem cell generation (Q27499837) (← links)
- Techniques of Human Embryonic Stem Cell and Induced Pluripotent Stem Cell Derivation (Q28066087) (← links)
- Induced pluripotent stem cells in dentistry (Q28078372) (← links)
- Osteogenic differentiation of amniotic fluid mesenchymal stromal cells and their bone regeneration potential (Q28085458) (← links)
- Instruction of circulating endothelial progenitors in vitro towards specialized blood-brain barrier and arterial phenotypes (Q28538281) (← links)
- A stable and reproducible human blood-brain barrier model derived from hematopoietic stem cells (Q28539764) (← links)
- Investigating core genetic-and-epigenetic cell cycle networks for stemness and carcinogenic mechanisms, and cancer drug design using big database mining and genome-wide next-generation sequencing data (Q28597874) (← links)
- Efficient generation of human iPSCs by a synthetic self-replicative RNA. (Q30558268) (← links)
- Derivation of Transgene-Free Rat Induced Pluripotent Stem Cells Approximating the Quality of Embryonic Stem Cells (Q33722410) (← links)
- In Vivo Roles of a Patient-Derived Induced Pluripotent Stem Cell Line (HD72-iPSC) in the YAC128 Model of Huntington's Disease. (Q33727646) (← links)
- A mystery unraveled: nontumorigenic pluripotent stem cells in human adult tissues (Q33911166) (← links)
- Efficient germ-line transmission obtained with transgene-free induced pluripotent stem cells (Q33972190) (← links)
- Regulation of EMT by KLF4 in gastrointestinal cancer (Q34021751) (← links)
- Non-viral expression of mouse Oct4, Sox2, and Klf4 transcription factors efficiently reprograms tadpole muscle fibers in vivo. (Q34030170) (← links)
- The potential of stem cell-based therapy for retinal repair (Q34095423) (← links)
- A 2,6-disubstituted 4-anilinoquinazoline derivative facilitates cardiomyogenesis of embryonic stem cells (Q34149769) (← links)
- ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells (Q34242167) (← links)
- High-risk human papillomavirus E6 protein promotes reprogramming of Fanconi anemia patient cells through repression of p53 but does not allow for sustained growth of induced pluripotent stem cells (Q34261778) (← links)
- Steps toward safe cell therapy using induced pluripotent stem cells (Q34325607) (← links)
- Homologous recombination DNA repair genes play a critical role in reprogramming to a pluripotent state (Q34332168) (← links)
- Probing the role of stochasticity in a model of the embryonic stem cell: heterogeneous gene expression and reprogramming efficiency (Q34378442) (← links)
- Controlling gene networks and cell fate with precision-targeted DNA-binding proteins and small-molecule-based genome readers (Q34381076) (← links)
- Ethics of iPSC-based clinical research for age-related macular degeneration: patient-centered risk-benefit analysis (Q34475775) (← links)
- Reprogramming suppresses premature senescence phenotypes of Werner syndrome cells and maintains chromosomal stability over long-term culture (Q34498165) (← links)
- DNA methylation profiles provide a viable index for porcine pluripotent stem cells (Q34541121) (← links)
- Advanced feeder-free generation of induced pluripotent stem cells directly from blood cells (Q34601924) (← links)
- Baculovirus as an ideal radionuclide reporter gene vector: a new strategy for monitoring the fate of human stem cells in vivo (Q34676290) (← links)
- Adult ciliary epithelial stem cells generate functional neurons and differentiate into both early and late born retinal neurons under non-cell autonomous influences (Q35024065) (← links)
- Evaluating the potential of poly(beta-amino ester) nanoparticles for reprogramming human fibroblasts to become induced pluripotent stem cells (Q35069104) (← links)
- Thyroid cell differentiation from murine induced pluripotent stem cells (Q35522249) (← links)
- High glutathione and glutathione peroxidase-2 levels mediate cell-type-specific DNA damage protection in human induced pluripotent stem cells (Q35623892) (← links)
- Advances in understanding the cell types and approaches used for generating induced pluripotent stem cells (Q35653333) (← links)
- Optical reprogramming of human cells in an ultrashort femtosecond laser microfluidic transfection platform (Q35831080) (← links)
- The current and future therapies of bone regeneration to repair bone defects (Q35852374) (← links)
- Rewinding the process of mammalian extinction (Q36007952) (← links)
- Mesenchymal stem cell-derived hepatocytes for functional liver replacement (Q36052620) (← links)
- Toward Personalized Medicine: Using Cardiomyocytes Differentiated From Urine-Derived Pluripotent Stem Cells to Recapitulate Electrophysiological Characteristics of Type 2 Long QT Syndrome (Q36141836) (← links)
- Zinc-finger nuclease-mediated correction of α-thalassemia in iPS cells (Q36528994) (← links)
- Fibromodulin reprogrammed cells: A novel cell source for bone regeneration. (Q36581714) (← links)
- Incompatible effects of p53 and HDAC inhibition on p21 expression and cell cycle progression. (Q36733204) (← links)